Dawn Christine Maroney Sells 16,535 Shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) President Dawn Christine Maroney sold 16,535 shares of the business’s stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $16.40, for a total value of $271,174.00. Following the sale, the president now owns 2,374,051 shares of the company’s stock, valued at approximately $38,934,436.40. The trade was a 0.69 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Dawn Christine Maroney also recently made the following trade(s):

• On Monday, March 17th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $15.99, for a total value of $479,700.00.
• On Wednesday, March 12th, Dawn Christine Maroney sold 27,243 shares of Alignment Healthcare stock. The stock was sold at an average price of $15.43, for a total value of $420,359.49.
• On Thursday, March 6th, Dawn Christine Maroney sold 278,917 shares of Alignment Healthcare stock. The stock was sold at an average price of $15.53, for a total value of $4,331,581.01.
• On Tuesday, February 18th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $13.72, for a total value of $411,600.00.
• On Wednesday, January 15th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $13.61, for a total value of $408,300.00.

Alignment Healthcare Trading Down 0.1 %

NASDAQ:ALHC opened at $17.18 on Friday. The stock has a fifty day moving average price of $14.79 and a two-hundred day moving average price of $12.63. The stock has a market capitalization of $3.30 billion, a price-to-earnings ratio of -22.31 and a beta of 1.49. The company has a debt-to-equity ratio of 1.82, a quick ratio of 1.60 and a current ratio of 1.60. Alignment Healthcare, Inc. has a 1 year low of $4.46 and a 1 year high of $17.38.

Analysts Set New Price Targets

ALHC has been the topic of several research analyst reports. William Blair reaffirmed an “outperform” rating on shares of Alignment Healthcare in a research report on Friday, February 28th. Stifel Nicolaus lifted their price target on Alignment Healthcare from $16.00 to $18.00 and gave the stock a “buy” rating in a research report on Friday, February 28th. JPMorgan Chase & Co. lifted their price target on Alignment Healthcare from $14.00 to $17.00 and gave the stock a “neutral” rating in a research report on Thursday, March 6th. Bank of America lifted their price target on Alignment Healthcare from $15.50 to $18.50 and gave the stock a “buy” rating in a research report on Tuesday, March 4th. Finally, Piper Sandler upped their price target on Alignment Healthcare from $14.00 to $21.00 and gave the stock an “overweight” rating in a research note on Tuesday, March 4th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, Alignment Healthcare currently has an average rating of “Moderate Buy” and a consensus target price of $14.83.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of ALHC. Wellington Management Group LLP raised its position in Alignment Healthcare by 77.9% in the fourth quarter. Wellington Management Group LLP now owns 7,438,500 shares of the company’s stock worth $83,683,000 after acquiring an additional 3,257,630 shares in the last quarter. T. Rowe Price Investment Management Inc. raised its position in Alignment Healthcare by 54.7% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 8,649,042 shares of the company’s stock worth $97,302,000 after acquiring an additional 3,059,596 shares in the last quarter. Millennium Management LLC raised its position in Alignment Healthcare by 588.3% in the fourth quarter. Millennium Management LLC now owns 3,388,602 shares of the company’s stock worth $38,122,000 after acquiring an additional 2,896,311 shares in the last quarter. Point72 Asset Management L.P. acquired a new stake in Alignment Healthcare in the fourth quarter valued at $20,087,000. Finally, Broad Bay Capital Management LP acquired a new stake in Alignment Healthcare in the fourth quarter valued at $18,804,000. Hedge funds and other institutional investors own 86.19% of the company’s stock.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.